Short‐Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial‐IRON Trial

Background The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial‐IRON trial showed short‐term cardiac magnetic resonance...

Full description

Bibliographic Details
Main Authors: Irene del Canto, Enrique Santas, Ingrid Cardells, Gema Miñana, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Raquel López‐Vilella, Luis Almenar, Vicent Bodí, Maria P. López‐Lereu, Jose V. Monmeneu, Juan Sanchis, David Moratal, Alicia M. Maceira, Rafael de la Espriella, Francisco J. Chorro, Antoni Bayés‐Genís, Julio Núñez
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022214